Downregulation of CD133 significantly sensitised MDR CRC cells to chemotherapeutic agents (DOX, MMC, VCR and CTX) (Fig. 4a) and markedly increased DOX uptake (Fig. 4b, c). Here, PROM1 is linked to colorectal carcinoma.